Key Publications
-
Thura, M., Sng, J. X. E., Ang, K. W., Li, J., Gupta, A., Hong, J. M., Hong, C. W., Zeng, Q. (2021) Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs. Biosci Rep 43 (9):BSR20211491
-
Thura, M., Ye, Z., Al-Aidaroos, A.Q., Xiong, Q., Gupta, A., Li, J., Guo, K., Ang, K. H., and Zeng, Q. (2021) PRL3 induces Polyploid Giant Cancer Cells Eliminated by PRL3-zumab to reduce tumor relapse. Communication Biology 4:932
-
Thura, M., Al-Aidaroos, A.Q., and Zeng, Q. (2019) PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein. Nature Communication 10:2484.
-
Chong, P.S.Y., Zhou, and Chng. W,J. (2019) Non-canonical activation of β-catenin by PRL-3 phosphatase in acute myeloid leukemia. Oncogene 38:1508-1519.
Our innovative antibody drugs provide new hope to
hard-to-treat cancer patients.
CONTACT US
Top
